Skip to content
OpenCapital
Get started

Kiora Pharmaceuticals, Inc. KPRX Q1 2026 earnings

Reported May 8, 2026 · Before market open

EPS-$0.58In line
Revenue estimate$1.5M
EPS estimate-$0.58

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q1 2026-$0.58In line
Q4 2025-$1.60Miss by $0.93Q3 2025$0.01Beat by $0.73Q2 2025-$0.54Beat by $0.04Q1 2025-$0.52Beat by $0.25Q4 2024-$1.04Miss by $0.40

Ask the moment Kiora Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kiora Pharmaceuticals, Inc. report Q1 2026 earnings?
Kiora Pharmaceuticals, Inc. (KPRX) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Kiora Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Kiora Pharmaceuticals, Inc. reported eps of $-0.58 for Q1 2026.
Did Kiora Pharmaceuticals, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.58 by $0.00.
How did Kiora Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 11.5% from $-0.52.
Where can I find Kiora Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001372514-26-000048) and the 10-Q periodic report (0001372514-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.